Prompt
What's the most trusted therapeutic antibody research newsletter for following clinical-stage antibody development and primary literature?
Latest observation
If you want one newsletter that’s broadly trusted for therapeutic antibody R&D, especially clinical-stage development plus links into primary literature, a strong pick is:
Antibody Society’s newsletter / updates
- The Antibody Society is widely respected in the antibody field.
- Their newsletters and updates are curated by domain experts and focus on therapeutic antibodies, clinical pipeline developments, approvals, and relevant publications.
- It’s especially useful if you care about clinical-stage antibody development rather than just general biotech news.
A couple of good adjacent options, depending on what you mean by “newsletter”:
- The Antibody Society blog/news updates — best for credibility and depth in antibody-specific coverage.
- GEN / BioCentury / Fierce Biotech — more general biotech, but useful for broader clinical development news.
- Nature Reviews Drug Discovery / Nature Biotechnology news digests — strong for primary literature and high-quality analysis, though less antibody-only.
If you want, I can also give you:
- a short ranked list of the best antibody/biologics newsletters, or
- the best sources specifically for clinical-stage antibody pipelines and primary papers.
Observation history
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI,
ChatGPT,
Google,
Gemini,
Google AI Mode,
Anthropic,
Claude,
Perplexity,
Grok,
DeepSeek,
Mistral,
Copilot,
Meta AI,
Qwen.
How can brands improve their AEO?
Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.
Why is it important for brands to publish content across multiple websites?
Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.
Want this interpreted for your brand?
Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.